mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.75 |
0.005 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
0.005 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.008 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |